Derivative Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Cash Flow Hedging Instruments

At March 31, 2024, April 2, 2023 and December 31, 2023, the notional amounts and fair values of the Company's foreign currency forward contracts designated as cash flow hedging instruments were as follows:

	March 31, 2024				April 2, 2023				December 31, 2023
Hedged transaction	Notional Amount		Fair Value		Notional Amount		Fair Value		Notional Amount		Fair Value
Inventory purchases	$	151.2	$	0.3	$	141.5	$	(5.1)	$	129.9	$	(1.7)
Sales	75.3		(0.2)		74.5		0.4		89.7		(0.2)
Production financing and other	30.7		(1.1)		123.7		0.8		31.7		(0.5)
Total	$	257.2	$	(1.0)	$	339.7	$	(3.9)	$	251.3	$	(2.4)

Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location

The fair values of the Company's foreign currency forward contracts designated as cash flow hedges are recorded in the Consolidated Balance Sheets at March 31, 2024, April 2, 2023 and December 31, 2023 as follows:

	March 31, 2024		April 2, 2023		December 31, 2023
Prepaid expenses and other current assets
Unrealized gains	$	2.4	$	2.7	$	0.5
Unrealized losses	(0.8)		(1.8)		(0.1)
Net unrealized gains	$	1.6	$	0.9	$	0.4
Other Assets
Unrealized gains	$	0.1	$	—	$	—
Net unrealized gains	$	0.1	$	—	$	—
Accrued liabilities
Unrealized gains	$	1.4	$	2.5	$	0.7
Unrealized losses	(4.1)		(7.3)		(3.5)
Net unrealized losses	$	(2.7)	$	(4.8)	$	(2.8)

Schedule of Derivative Instruments, Gain (Loss) in Statement of Operations

Net gains (losses) on cash flow hedging activities have been reclassified from other comprehensive earnings (loss) to net earnings for the quarters ended March 31, 2024 and April 2, 2023 as follows:

	Quarter Ended
	March 31, 2024		April 2, 2023
Statements of Operations Classification
Cost of sales	$	0.1	$	2.5
Net revenues	(0.1)		0.1
Other	(0.1)		(0.2)
Net realized (losses) gains	$	(0.1)	$	2.4

Schedule of Fair Values of Undesignated Derivative Financial Instruments

At March 31, 2024, April 2, 2023 and December 31, 2023, the fair values of the Company's undesignated derivative financial instruments were recorded in the Consolidated Balance Sheets as follows:

	March 31, 2024		April 2, 2023		December 31, 2023
Prepaid expenses and other current assets
Unrealized gains	$	7.0	$	6.5	$	0.3
Unrealized losses	(0.2)		(4.3)		—
Net unrealized gains	$	6.8	$	2.2	$	0.3
Accrued liabilities
Unrealized gains	$	—	$	—	$	1.4
Unrealized losses	(0.2)		(0.3)		(2.5)
Net unrealized losses	$	(0.2)	$	(0.3)	$	(1.1)